Ketorolin 30 mg

SF0426OA6643/072026
13/07/2028

Active ingredient:
Ketorolac Tromethamine 30 mg.

Therapeutic indications:
Indicated for the short-term (5-days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a
postoperative setting.

Dosage form
Solution for I.M or I.V Injection.

Click here to download full Insert leaflet

Mini-Guava

Active ingredient:Guava leaves 0.125 ml, Tilia flowers powder Extract...

صورة أملاح معالجة الجفاف ORS لتعويض السوائل

O.R.S

Active ingredient:0.52 g Sodium chloride, 2.7 g Anhydrous glucose,...

صورة دواء فارسيرت جل Pharsert مضاد للفطريات

Pharsert Gel

Active ingredient:20 mg/g Sertaconazole. Therapeutic indications:Indicated for the topical...

Contact Us

Ketorolin 30 mg

Mini-Guava

O.R.S

Pharsert Gel

COMMITED TO
QUALITY CARE

Contact Us

Ketorolin 30 mg

Mini-Guava

O.R.S

Pharsert Gel

COMMITED TOQUALITY CARE

COMMITED TO
QUALITY CARE